Literature DB >> 10393694

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.

K Kuwano1, N Hagimoto, M Kawasaki, T Yatomi, N Nakamura, S Nagata, T Suda, R Kunitake, T Maeyama, H Miyazaki, N Hara.   

Abstract

The Fas ligand is predominantly expressed in activated T lymphocytes and is one of the major effector molecules of cytotoxic T lymphocytes and natural killer cells. Previously, we found excessive apoptosis of epithelial cells and infiltrating lymphocytes expressing Fas ligand mRNA in the lung tissue of bleomycin-induced pulmonary fibrosis in mice. Here we demonstrated that the administration of a soluble form of Fas antigen or anti-Fas ligand antibody prevented the development of this model and that lpr and gld mice were resistant against the induction of pneumopathy. These results suggest that the Fas-Fas ligand pathway plays an essential role in the development of pulmonary fibrosis and that preventing this pathway could have therapeutic value in lung injury and fibrosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393694      PMCID: PMC408400          DOI: 10.1172/JCI5628

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

Authors:  T Brunner; R J Mogil; D LaFace; N J Yoo; A Mahboubi; F Echeverri; S J Martin; W R Force; D H Lynch; C F Ware
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

2.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Authors:  B Lowin; M Hahne; C Mattmann; J Tschopp
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

3.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

4.  Expression of the Fas ligand in cells of T cell lineage.

Authors:  T Suda; T Okazaki; Y Naito; T Yokota; N Arai; S Ozaki; K Nakao; S Nagata
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

5.  Human Fas ligand: gene structure, chromosomal location and species specificity.

Authors:  T Takahashi; M Tanaka; J Inazawa; T Abe; T Suda; S Nagata
Journal:  Int Immunol       Date:  1994-10       Impact factor: 4.823

6.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

Authors:  J Dhein; H Walczak; C Bäumler; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

Review 8.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

9.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

10.  Purification and characterization of the Fas-ligand that induces apoptosis.

Authors:  T Suda; S Nagata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  94 in total

1.  A Fas pathway to pulmonary fibrosis.

Authors:  H A Chapman
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 2.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis.

Authors:  Seiji Hayashi; Kin'ya Abe; Hiroto Matsuoka; Sho Goya; Hiroshi Morishita; Masahide Mori; Toru Arai; Hiroshi Kida; Kazumi Nishino; Yoshito Takeda; Tadashi Osaki; Isao Tachibana; Kentaro Kimura; Soichiro Yokota; Yoshikazu Inoue; Mitsunori Sakatani
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

4.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

5.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

6.  Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells.

Authors:  Sean R Stowell; Sougata Karmakar; Caleb J Stowell; Marcelo Dias-Baruffi; Rodger P McEver; Richard D Cummings
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

7.  Relationship of acute lung inflammatory injury to Fas/FasL system.

Authors:  Thomas A Neff; Ren-Feng Guo; Simona B Neff; J Vidya Sarma; Cecilia L Speyer; Hongwei Gao; Kurt D Bernacki; Markus Huber-Lang; Stephanie McGuire; L Marco Hoesel; Niels C Riedemann; Beatrice Beck-Schimmer; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.

Authors:  Sean R Stowell; Connie M Arthur; Kristin A Slanina; John R Horton; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

10.  Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.

Authors:  S Segawa; D Goto; Y Yoshiga; M Sugihara; T Hayashi; Y Chino; I Matsumoto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.